GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Well Corp (NYSE:AMWL) » Definitions » ROE %

American Well (American Well) ROE % : -40.22% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is American Well ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. American Well's annualized net income for the quarter that ended in Dec. 2023 was $-194.3 Mil. American Well's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $483.2 Mil. Therefore, American Well's annualized ROE % for the quarter that ended in Dec. 2023 was -40.22%.

The historical rank and industry rank for American Well's ROE % or its related term are showing as below:

AMWL' s ROE % Range Over the Past 10 Years
Min: -100.74   Med: -36.22   Max: -14.32
Current: -100.74

During the past 6 years, American Well's highest ROE % was -14.32%. The lowest was -100.74%. And the median was -36.22%.

AMWL's ROE % is ranked worse than
91.13% of 609 companies
in the Healthcare Providers & Services industry
Industry Median: 4.12 vs AMWL: -100.74

American Well ROE % Historical Data

The historical data trend for American Well's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Well ROE % Chart

American Well Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial - -48.95 -14.32 -23.48 -88.37

American Well Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.78 -180.87 -56.02 -96.76 -40.22

Competitive Comparison of American Well's ROE %

For the Health Information Services subindustry, American Well's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Well's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, American Well's ROE % distribution charts can be found below:

* The bar in red indicates where American Well's ROE % falls into.



American Well ROE % Calculation

American Well's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-675.164/( (1063.877+464.219)/ 2 )
=-675.164/764.048
=-88.37 %

American Well's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-194.348/( (502.273+464.219)/ 2 )
=-194.348/483.246
=-40.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


American Well  (NYSE:AMWL) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-194.348/483.246
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-194.348 / 282.708)*(282.708 / 612.353)*(612.353 / 483.246)
=Net Margin %*Asset Turnover*Equity Multiplier
=-68.75 %*0.4617*1.2672
=ROA %*Equity Multiplier
=-31.74 %*1.2672
=-40.22 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-194.348/483.246
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-194.348 / -195.132) * (-195.132 / -227.82) * (-227.82 / 282.708) * (282.708 / 612.353) * (612.353 / 483.246)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.996 * 0.8565 * -80.58 % * 0.4617 * 1.2672
=-40.22 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


American Well ROE % Related Terms

Thank you for viewing the detailed overview of American Well's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


American Well (American Well) Business Description

Traded in Other Exchanges
N/A
Address
75 State Street, 26th Floor, Boston, MA, USA, 02109
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
Executives
Vukasin Paunovich officer: EVP, Enterprise Platforms C/O AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Kurt Knight officer: Chief Operating Officer AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Robert Shepardson officer: Chief Financial Officer C/O AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Paul Francis Mcneice officer: Vice President of Accounting 20 JOHANNA DRIVE, READING MA 01867
Deborah C Jackson director C/O JOHN HANCOCK, 601 CONGRESS STREET, BOSTON MA 02210
Peter L. Slavin director AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Phyllis Gotlib officer: President, International AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Ido Schoenberg director, 10 percent owner, officer: Chairman, co-CEO AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Roy Schoenberg director, 10 percent owner, officer: President, co-CEO AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Kathy Johnson Weiler officer: See Remarks C/O AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON, MA 02109
Bradford Gay officer: Senior VP, General Counsel AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Serkan Kutan officer: Chief Technology Officer AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Amber Howe officer: Chief People Officer AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Stephen J. Schlegel director AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109
Robert Thomas Webb director C/O AMERICAN WELL CORPORATION, 75 STATE STREET, 26TH FLOOR, BOSTON MA 02109